Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_assertion type Assertion NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_head.
- NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_assertion description "[Initially classified in the myelodysplastic syndromes (MDSs), chronic myelomonocytic leukemia (CMML) is currently considered as a MDS/myeloproliferative neoplasm.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_provenance.
- NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_assertion evidence source_evidence_literature NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_provenance.
- NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_assertion SIO_000772 24595958 NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_provenance.
- NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_assertion wasDerivedFrom befree-20150227 NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_provenance.
- NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_assertion wasGeneratedBy ECO_0000203 NP873202.RAQlm_0Molm_k_BE-SL3QjmtYbMEDS-mJUvEfYzmRhEhk130_provenance.